Groupe la Francaise’s Moderna MRNA Stock Holding History

Groupe la Francaise’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$241K	Sell	5,005 -1,000	-17%	-$46.7K	﹤0.01%	369
2025 Q4	$177K	Sell	6,005 -12,409	-67%	-$337K	﹤0.01%	373
2025 Q3	$424K	Buy	18,414 +8,569	+87%	+$239K	0.01%	367
2025 Q2	$270K	Sell	9,845 -160	-2%	-$4.21K	﹤0.01%	356
2025 Q1	$338K	Sell	10,005 -17,105	-63%	-$607K	0.01%	339
2024 Q4	$1.07M	Buy	+27,110	New	+$1.3M	0.03%	206

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Groupe la Francaise's MRNA Position: Q1 2026 in Review

Groupe la Francaise reduced its Moderna (MRNA) stake by 17% in Q1 2026, selling an estimated $46.7K and leaving 5,005 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #369.

Groupe la Francaise first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.07M in Q4 2024. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

Groupe la Francaise held 5,005 shares of Moderna worth $241K as of Q1 2026.
Groupe la Francaise sold 1,000 Moderna shares in Q1 2026, an estimated $46.7K.
Moderna made up ﹤0.01% of Groupe la Francaise's portfolio in Q1 2026, its #369 holding.
Groupe la Francaise first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
Groupe la Francaise's Moderna position peaked at $1.07M in Q4 2024.
722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.